IRIS
BIANCHI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 97.254
AS - Asia 16.130
EU - Europa 12.007
Continente sconosciuto - Info sul continente non disponibili 2.739
SA - Sud America 2.239
AF - Africa 250
OC - Oceania 58
Totale 130.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 96.238
SG - Singapore 8.100
IT - Italia 3.463
CN - Cina 2.771
BR - Brasile 1.808
RU - Federazione Russa 1.770
HK - Hong Kong 1.305
VN - Vietnam 1.172
IE - Irlanda 1.146
DE - Germania 1.105
BD - Bangladesh 896
FR - Francia 881
UA - Ucraina 824
GB - Regno Unito 742
CA - Canada 555
SE - Svezia 538
JP - Giappone 441
FI - Finlandia 408
IN - India 318
PL - Polonia 296
NL - Olanda 274
KR - Corea 251
ID - Indonesia 150
AR - Argentina 142
MX - Messico 118
ES - Italia 114
TR - Turchia 95
AT - Austria 91
EC - Ecuador 80
IQ - Iraq 79
UZ - Uzbekistan 78
ZA - Sudafrica 73
CO - Colombia 70
BE - Belgio 60
MY - Malesia 60
AU - Australia 54
JM - Giamaica 53
PH - Filippine 51
CR - Costa Rica 47
PK - Pakistan 43
AE - Emirati Arabi Uniti 42
TT - Trinidad e Tobago 40
HN - Honduras 38
LT - Lituania 38
VE - Venezuela 38
EG - Egitto 37
SA - Arabia Saudita 37
RO - Romania 35
IL - Israele 31
PR - Porto Rico 31
CL - Cile 30
NI - Nicaragua 30
CH - Svizzera 29
MA - Marocco 29
GT - Guatemala 28
KG - Kirghizistan 28
NG - Nigeria 28
TH - Thailandia 28
EU - Europa 25
JO - Giordania 24
PE - Perù 23
PY - Paraguay 23
CZ - Repubblica Ceca 22
IR - Iran 21
PT - Portogallo 20
SV - El Salvador 20
TN - Tunisia 19
EE - Estonia 18
NP - Nepal 18
UY - Uruguay 18
AZ - Azerbaigian 17
DK - Danimarca 16
DZ - Algeria 16
SK - Slovacchia (Repubblica Slovacca) 16
HU - Ungheria 15
RS - Serbia 15
GP - Guadalupe 14
DO - Repubblica Dominicana 13
GR - Grecia 13
KE - Kenya 12
CW - ???statistics.table.value.countryCode.CW??? 10
HR - Croazia 10
LB - Libano 10
PA - Panama 10
TW - Taiwan 10
BB - Barbados 8
KZ - Kazakistan 8
ET - Etiopia 7
GE - Georgia 7
OM - Oman 7
AL - Albania 6
SY - Repubblica araba siriana 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
GH - Ghana 5
LV - Lettonia 5
NO - Norvegia 5
Totale 127.894
Salva come PNG Salva come JPEG
Città #
Wilmington 23.106
Houston 21.939
Woodbridge 17.402
Ashburn 3.792
Singapore 3.486
Fairfield 3.255
San Jose 2.324
Chandler 1.871
Seattle 1.362
Ann Arbor 1.301
Hong Kong 1.274
Cambridge 1.200
Council Bluffs 1.110
Dublin 1.044
Beijing 993
Medford 741
Rome 724
New York 699
Santa Clara 679
Jacksonville 658
Dearborn 571
The Dalles 569
Los Angeles 565
Dallas 381
Tokyo 376
Ho Chi Minh City 366
Lawrence 348
Buffalo 313
Milan 293
Hanoi 285
Lauterbourg 262
Zhengzhou 257
Moscow 251
San Diego 231
Menlo Park 200
São Paulo 198
Boardman 185
Chicago 182
Munich 179
Denver 170
North Bergen 165
Kraków 162
Atlanta 150
Helsinki 147
Toronto 142
Montreal 137
London 134
Orem 127
Redwood City 110
Nuremberg 106
Phoenix 104
Redondo Beach 96
Brooklyn 95
Warsaw 95
Shanghai 94
Naples 90
Chennai 86
Seoul 86
Lappeenranta 82
Jakarta 81
Frankfurt am Main 78
Mülheim 74
San Francisco 69
Amsterdam 67
Cedarhurst 65
Norwalk 62
Boston 59
Guangzhou 57
Manchester 57
Brussels 54
Salt Lake City 53
Haiphong 52
Nanjing 52
Rio de Janeiro 51
Stockholm 50
Columbus 49
Florence 49
Hefei 49
Johannesburg 48
Colorado Springs 47
Da Nang 47
Belo Horizonte 44
Detroit 43
Bologna 42
Falls Church 41
Verona 41
Charlotte 40
San Mateo 40
Elk Grove Village 38
Engelhard 38
Philadelphia 38
Vienna 38
Brasília 37
Mexico City 37
Paris 37
Las Vegas 35
Newark 35
Dhaka 34
Kingston 34
Miami 32
Totale 99.344
Salva come PNG Salva come JPEG
Nome #
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data 1.657
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.402
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.251
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 789
Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions 775
Psoriasiform sarcoidosis: an unusual variety 720
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 709
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 633
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 606
Efficacy and safety of infliximab in psoriatic patients over the age of 65 565
Is weekly dose of adalimumab a simple approach for resistant psoriasis? 560
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 552
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. 552
Leflunomide-induced DRESS syndrome 542
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 531
Topical lactoferrin can improve stable psoriatic plaque 528
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 521
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 512
Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis 510
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 509
Apremilast for the treatment of psoriasis. 499
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 496
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. 495
Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review 495
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 494
Angiosarcoma cutaneo epitelioide 493
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry. 491
Tazarotene as alternative topical treatment for onychomycosis 484
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 482
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 478
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 477
Cheratodermia puntata porocheratosica 476
Actinic keratosis treated with an immune response modifier: a case report of six patients 472
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 471
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 467
Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis 467
Stress reactivity in psoriatic patients 466
Treatment of trachyonychia with tazarotene 466
Brodalumab for the treatment of psoriasis 466
Psodisk, a new visual method for assessing the burden of psoriasis on patients 463
Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast 462
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 461
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 459
Treatment of kerion with fluconazole [30] 458
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 456
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 454
Pachydermoperiostosis: Study of epidermal growth factor and steroid receptors 452
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 452
Pachydermodactyly: a case of an unusual type of reactive digital fibromatosis 452
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 450
Phrynoderma: a cutaneous sign of an inadequate diet 447
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 446
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 445
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 445
Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids 442
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis 442
Non-familial porphyria cutanea tarda: a case report of a rare disease 440
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 439
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 439
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 437
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 437
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 435
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 434
Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features 432
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 432
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 432
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 431
Analysis of risk factors in cutaneous malignant melanoma: an italian population-based study 431
Tildrakizumab for treating psoriasis 430
Severe acne successfully treated with etanercept 429
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 428
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 427
Quality-of-life impairment in hidradenitis suppurativa 427
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients 427
Abnormal bcl-2 and 'tissue' transglutaminase expression in psoriatic skin 425
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 425
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 424
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 423
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 422
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 422
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections 422
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 421
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 421
Elementi di dermatologia 420
Erysipeloid cutaneous metastasis from bladder carcinoma 419
Confocal reflectance microscopy in pityriasis rubra pilaris 417
Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review 417
Allergic contact dermatitis of the lip margins from para-tertiary-butylphenol in a lip liner 416
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis 415
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 415
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 413
A hair cast case: chemical and structural study 412
Acute facial gangrene in a diabetic 411
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 411
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 411
Mixoma intramuscolare del volto 410
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 410
Tofacitinib for the treatment of psoriasis 410
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 410
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study 409
Totale 49.863
Salva come PNG Salva come JPEG
Categoria #
all - tutte 359.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 359.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.046 0 0 0 176 177 306 311 188 263 311 285 1.029
2022/20235.053 487 585 198 611 457 1.113 421 285 465 74 232 125
2023/20242.278 247 69 139 72 182 424 225 183 53 192 93 399
2024/202512.242 332 2.047 1.127 652 250 848 808 556 1.032 962 2.057 1.571
2025/202620.291 1.477 807 2.148 1.549 1.639 697 2.512 2.243 2.388 1.889 1.752 1.190
2026/20278.725 1.298 1.141 3.774 2.512 0 0 0 0 0 0 0 0
Totale 130.677